Logo of Twareat Medical Center (TMC)
Twareat Medical Center (TMC) issued the registration document for the direct listing of its shares on Nomu-Parallel Market, setting the price guidance at SAR 12 per share.
Earlier this month, the Capital Market Authority (CMA) approved the company’s application for a direct listing on Nomu.
Subscription to the company's shares will be limited to qualified investors as defined in the glossary used in the CMA's regulations and rules.
Twareat, founded in 2013 in Al Khobar, operates across various sectors. Its activities, as per its commercial register, include general construction and the renovation of residential and non-residential buildings.
The company engages in the wholesale trade of medical devices, equipment, and supplies, alongside managing warehouses for medical equipment and products. It also provides operational management for hospitals, general medical complexes, and clinics.
Other services include managing day surgery centers, ambulance transport service centers, and medical laboratories. The company also specializes in home-based healthcare services, mobile medical clinics, telemedicine centers, and the operation of radiology and allied medical services.
Twareat operates through four business divisions: remote clinics, industrial clinics, medical operations, and medical centers management.
|
Company Profile |
|
|
Company |
Twareat Medical Center |
|
Market |
Nomu-Parallel Market |
|
Core Activities |
Medical care services |
|
Status |
Active |
|
Capital |
SAR 40 mln |
|
Direct Listing Profile |
|
|
Offer shares |
40 mln |
|
Par value |
SAR 12 |
|
Price guidance |
SAR 1 |
|
Method of setting opening price |
Based on the supply and demand for the stock through the pre-opening auction mechanism. During this period, investors can place buy/sell orders, after which the trading system defines the fair price at which orders are executed after being matched during the auction period. The execution price will be the opening price, with a ±30% daily fluctuation limit
The price guidance is considered a reference only for the fair market value, which is the debut price for the first day only |
|
Qualified investors |
- Qualified investors - Current shareholders (excluding owners of 5% or more, to whom the lock-up period shall apply) |
|
Company Shareholders |
||
|
Shareholder |
Pre-Direct Listing |
|
|
Number of shares (mln) |
Ownership (%) |
|
|
Tarek Al-Hamdan* |
11.67 |
29.18 |
|
AYYAN Investment |
10.00 |
25.00 |
|
Bait Lulua Co. |
4.61 |
11.53 |
|
Abdullah Al-Hamdan |
2.60 |
6.49 |
|
Amer Al-Amer |
1.56 |
3.90 |
|
Khalid Al-Hamdan |
1.56 |
3.90 |
|
Others owning a <3% stake (121 shareholders) |
8.00 |
20.00 |
|
Qualified investors |
-- |
-- |
|
Total |
40 |
100.00% |
|
Additional Information |
|
|
Financial Advisor |
Aldukheil Capital |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}